News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
754,787 Results
Type
Article (44481)
Company Profile (267)
Press Release (710026)
Multimedia
Podcasts (135)
Webinars (23)
Section
Business (211271)
Career Advice (2120)
Deals (36868)
Drug Delivery (148)
Drug Development (83662)
Employer Resources (176)
FDA (16966)
Job Trends (15557)
News (358038)
Policy (34159)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2654)
Accelerated approval (55)
ADA (44)
Adcomms (31)
Allergies (198)
Alliances (51592)
ALS (231)
Alzheimer's disease (1863)
Antibody-drug conjugate (ADC) (535)
Approvals (17444)
Artificial intelligence (757)
ASCO (333)
Autoimmune disease (348)
Automation (64)
Bankruptcy (375)
Best Places to Work (11768)
BIO (66)
BIOSECURE Act (21)
Biosimilars (243)
Biotechnology (162)
Bladder cancer (204)
Brain cancer (79)
Breast cancer (813)
Cancer (6395)
Cardiovascular disease (521)
Career advice (1811)
Career pathing (46)
CAR-T (360)
CDC (61)
Celiac Disease (3)
Cell therapy (981)
Cervical cancer (56)
Clinical research (73168)
Collaboration (2269)
Commercialization (1)
Company closure (5)
Compensation (1503)
Complete response letters (93)
COVID-19 (2828)
CRISPR (122)
C-suite (1275)
Cystic fibrosis (161)
Data (8703)
Decentralized trials (3)
Denatured (41)
Depression (179)
Dermatology (97)
Diabetes (672)
Diagnostics (7119)
Digital health (64)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (375)
Drug pricing (222)
Drug shortages (34)
Duchenne muscular dystrophy (309)
Earnings (93976)
Editorial (70)
Employer branding (21)
Employer resources (158)
Events (123601)
Executive appointments (1162)
FDA (21041)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (35)
Funding (1876)
Gene editing (253)
Generative AI (64)
Gene therapy (773)
GLP-1 (1147)
Government (4898)
Grass and pollen (7)
Guidances (421)
Healthcare (19334)
Hematology (195)
HIV (90)
Huntington's disease (63)
IgA nephropathy (113)
Immunology and inflammation (316)
Immuno-oncology (108)
Indications (223)
Infectious disease (3196)
Inflammatory bowel disease (230)
Inflation Reduction Act (14)
Influenza (142)
Intellectual property (325)
Interviews (332)
IPO (16961)
IRA (57)
Job creations (4077)
Job search strategy (1502)
JPM (65)
Kidney cancer (20)
Labor market (113)
Layoffs (605)
Leadership (44)
Legal (8428)
Liver cancer (104)
Longevity (36)
Lung cancer (843)
Lymphoma (480)
Machine learning (67)
Management (62)
Manufacturing (1192)
Marketing (4)
MASH (215)
Medical affairs (1)
Medical device (14085)
Medtech (14258)
Mergers & acquisitions (21223)
Metabolic disorders (1690)
mRNA (240)
Multiple sclerosis (200)
NASH (18)
Neurodegenerative disease (466)
Neuropsychiatric disorders (115)
Neuroscience (3534)
Neurotech (1)
NextGen: Class of 2026 (6650)
Non-profit (4587)
Now hiring (82)
Obesity (783)
Opinion (323)
Ovarian cancer (242)
Pain (284)
Pancreatic cancer (355)
Parkinson's disease (396)
Partnered (37)
Patents (652)
Patient recruitment (774)
Peanut (70)
People (61971)
Pharmaceutical (71)
Pharmacy benefit managers (35)
Phase 1 (22715)
Phase 2 (32204)
Phase 3 (24097)
Pipeline (9958)
Policy (349)
Postmarket research (2661)
Preclinical (9669)
Press Release (68)
Prostate cancer (337)
Psychedelics (61)
Radiopharmaceuticals (353)
Rare diseases (1221)
Real estate (6324)
Recruiting (73)
Regulatory (26756)
Reports (57)
Research institute (2473)
Resumes & cover letters (363)
Rett syndrome (46)
RNA editing (27)
RSV (90)
Schizophrenia (191)
Series A (321)
Series B (237)
Service/supplier (11)
Sickle cell disease (123)
Special edition (28)
Spinal muscular atrophy (171)
Sponsored (49)
Startups (3800)
State (2)
Stomach cancer (19)
Supply chain (138)
Tariffs (99)
The Weekly (92)
Vaccines (1178)
Venture capital (124)
Weight loss (510)
Women's health (139)
Worklife (21)
Date
Today (116)
Last 7 days (507)
Last 30 days (2465)
Last 365 days (30868)
2026 (16528)
2025 (30671)
2024 (35714)
2023 (40626)
2022 (51797)
2021 (56325)
2020 (54788)
2019 (47394)
2018 (35768)
2017 (33134)
2016 (32661)
2015 (38614)
2014 (32516)
2013 (27630)
2012 (29730)
2011 (30487)
2010 (28500)
Location
Africa (807)
Alabama (93)
Alaska (7)
Arizona (373)
Arkansas (16)
Asia (42888)
Australia (6885)
California (14090)
Canada (3997)
China (1537)
Colorado (601)
Connecticut (613)
Delaware (438)
Europe (92395)
Florida (2129)
Georgia (447)
Hawaii (3)
Idaho (63)
Illinois (1174)
India (102)
Indiana (641)
Iowa (25)
Japan (613)
Kansas (135)
Kentucky (51)
Louisiana (60)
Maine (76)
Maryland (1670)
Massachusetts (10139)
Michigan (380)
Minnesota (764)
Mississippi (6)
Missouri (149)
Montana (33)
Nebraska (30)
Nevada (150)
New Hampshire (84)
New Jersey (3693)
New Mexico (31)
New York (3712)
North Carolina (1791)
North Dakota (9)
Northern California (7113)
Ohio (420)
Oklahoma (24)
Oregon (46)
Pennsylvania (2806)
Puerto Rico (31)
Rhode Island (52)
South America (1180)
South Carolina (88)
South Dakota (2)
Southern California (5592)
Tennessee (231)
Texas (2265)
United States (49823)
Utah (419)
Vermont (2)
Virginia (360)
Washington D.C. (81)
Washington State (1122)
West Virginia (4)
Wisconsin (141)
Wyoming (2)
754,787 Results for "inmed pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer’s Disease Program
• Human Organoid Data Supports the Therapeutic Rationale for INM-901 Program Ahead of Human Clinical Trials • Consistent Anti-Inflammatory Effects Demonstrate Translation from Animal Models to Three-Dimensional Human Brain Tissue Systems
March 23, 2026
·
7 min read
Press Releases
InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements
June 4, 2026
·
3 min read
Press Releases
InMed Pharmaceuticals Amends Preferred Investment Options
May 19, 2026
·
1 min read
Press Releases
InMed Pharmaceuticals Amends Preferred Investment Options
April 27, 2026
·
4 min read
Press Releases
InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies
May 19, 2026
·
14 min read
Press Releases
InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance
March 27, 2026
·
5 min read
Press Releases
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
March 6, 2026
·
5 min read
Press Releases
InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update
Advances INM-901 program, addressing multiple key biological pathways implicated in Alzheimer’s disease pathology Further develops INM-089 demonstrating neuroprotection in the treatment of dry Age-related Macular Degeneration Cash of $11.1M to support pharmaceutical developments into the fourth quarter of calendar year 2026
September 23, 2025
·
12 min read
Press Releases
InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
May 7, 2026
·
10 min read
Press Releases
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
March 9, 2026
·
7 min read
1 of 75,479
Next
